Agile Therapeutics (AGRX) Fails to deliver data

Key failure to deliver metrics for Agile Therapeutics :

• Last SEC data release: 2025-03-31
• Last 15 days FTD volume: N/A
• Last 3 months FTD volume: N/A
• Last year FTD volume: N/A

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Agile Therapeutics (AGRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Agile Therapeutics (AGRX) - since 2023

Agile Therapeutics (AGRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
TherapeuticsMD TXMD	€0.46 M	€0.63 M	🇺🇸 USA
Antares Pharma ATRS	N/A	€5.91 M	🇺🇸 USA
Johnson & Johnson JNJ	€17.09 M	€0.20 B	🇺🇸 USA
Merck MRK	€57.2 M	€0.17 B	🇺🇸 USA
Pfizer PFE	€33.22 M	€0.35 B	🇺🇸 USA